Financing ·
Endovia sells 526,582 shares to C/M Capital for $81,831 under existing ELOC agreement
EDVAEndovia Health Sciences, Inc.
On September 30, 2026, Endovia Health Sciences sold and issued 526,582 shares of common stock to C/M Capital Master Fund, LP. The transaction was executed pursuant to a Securities Purchase Agreement dated September 19, 2025, generating total gross proceeds of $81,830.84. The sale relied on the exemption from registration under Section 4(a)(2) and Rule 506(b). This issuance is part of an existing Equity Line of Credit (ELOC) agreement previously disclosed in September 2025. Endovia Health Sciences operates in the healthcare sector, focusing on medical device innovation.